Moreover, hepatocellular carcinoma (HCC) cells treated with recombinant COMP enhanced migration and invasion which was found to be related with the PI3k/AKT pathway through the CD36 receptor, a known receptor for the thrombospondin family [6,7,8]. Here, COMP is linked to hepatocellular carcinoma.